Name of this trial: ONO-0530-03-001 (INTREPID) What type of cancer is this for? Polycythemia Vera Who is this trial for? Patients with phlebotomy dependent polycythemia vera What biomarkers are involved? JAK2 Mutation What is the National Clinical Trial #? NCT07429266; https://clinicaltrials.gov/study/NCT07429266 Brief summary of this trial: A Phase 3 Randomized, Double-blind, Placebo-controlled Global Study of
Phone: (800) 411-7999
